Hone Health

About Hone Health

Hone Health launched in 2018 with a mission to modernize men’s health care through at-home diagnostics and telehealth consultations. The platform has since expanded aggressively into GLP-1 weight management, offering both liraglutide and semaglutide (brand-name and compounded formulations) at monthly costs between $149 and $350. What sets Hone apart from most GLP-1 telehealth providers is its foundation in hormone testing — every patient receives comprehensive lab work as part of the onboarding process, giving clinicians a metabolic baseline that informs treatment decisions.

Hone’s reputation metrics are among the strongest we have reviewed. The platform holds a 4.8 rating on Trustpilot across 10,900+ reviews, an exceptional score at that volume. It also carries an A+ rating with the BBB, the highest possible grade and a rarity in the telehealth weight loss space. Together, these metrics indicate a company that resolves complaints effectively and maintains consistently high patient satisfaction.

The clinical model at Hone qualifies as high-support by our evaluation criteria. Patients receive included lab testing, ongoing provider access, and treatment plans that account for hormonal factors — particularly testosterone levels — that directly influence weight loss outcomes in men. This hormone-aware approach is genuinely differentiated: most GLP-1 providers treat weight in isolation, while Hone recognizes that low testosterone, insulin resistance, and metabolic dysfunction are often interconnected. For men over 35 experiencing both weight gain and fatigue or low libido, this integrated model can address root causes rather than just symptoms.

Pricing is competitive for the level of care provided. At $149/month on the low end, Hone undercuts several competitors that offer less clinical depth. The upper range of $350/month aligns with brand-name GLP-1 pricing across the industry. Hone also includes the cost of initial lab work in its program fees, whereas many competitors charge separately for diagnostics or skip them entirely. The value proposition is strong, particularly for patients who would otherwise need to coordinate lab testing through a separate provider.

The primary limitation is Hone’s men’s health focus. While the platform does not explicitly exclude women, its clinical protocols, marketing, and provider expertise are optimized for male patients. Women seeking GLP-1 treatment will find more tailored options elsewhere. For men, however, Hone represents one of the most clinically rigorous and well-reviewed telehealth GLP-1 providers currently available.

At a Glance